NCT06942858

Brief Summary

The goal of this clinical trial is to learn if dTMS targeting the ACC can be used to rapidly and effectively treat AN. A randomized controlled study design is adopted, in which patients with AN are divided into the CBT+dTMS treatment group and CBT+pseudostimulation group by 1:1 randomization, followed by a 6-week intervention and a half-year follow-up to clarify whether CBT combined with dTMS is superior to single CBT treatment for AN.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
33mo left

Started Apr 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Apr 2025Dec 2028

First Submitted

Initial submission to the registry

April 17, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 24, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

April 30, 2025

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

May 11, 2025

Status Verified

April 1, 2025

Enrollment Period

3.4 years

First QC Date

April 17, 2025

Last Update Submit

May 6, 2025

Conditions

Keywords

anorexia nervosaDeep transcranial magnetic stimulationanterior cingulate cortex

Outcome Measures

Primary Outcomes (1)

  • Body Mass Index (BMI)

    Calculation: BMI = weight (kg) divided by the square of height (m)

    week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)

Secondary Outcomes (7)

  • Eating Disorder Examination Questionnaire (EDE-Q6.0)

    week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)

  • Eating Disorder Inventory (EDI-II)

    week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)

  • Beck Depression Inventory (BDI)

    week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)

  • Beck Anxiety Inventory (BAI)

    week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)

  • Self-assessed Compulsive Questionnaire for Eating Disorders (SR-YBC-EDS)

    week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)

  • +2 more secondary outcomes

Study Arms (2)

CBT+dTMS treatment group

EXPERIMENTAL

CBT+dTMS treatment group has 55 patients. Each patient receives 12 individual sessions of CBT for 50 minutes 2 times per week for 6 weeks. dTMS intervention use real coils, targeting ACC, given 5 times per week (Monday to Friday) for 6 consecutive weeks.

Device: Deep transcranial magnetic stimulationBehavioral: cognitive behavior therapyOther: Basic treatment

CBT+pseudo-stimulation group

ACTIVE COMPARATOR

CBT+Pseudo-stimulation group has 55 patients. Each patient receives 12 individual sessions of CBT for 50 minutes 2 times per week for 6 weeks. dTMS intervention uses sham coils (with the same parameters as real dTMS and generating the same noise as real coils, but without the magnetic field). It is given 5 times per week (Monday to Friday) for 6 consecutive weeks.

Behavioral: cognitive behavior therapyDevice: Sham deep transcranial magnetic stimulationOther: Basic treatment

Interventions

M-100 Ultimate pulsed magnetic field stimulator is used for dTMS treatment. The coil is positioned 4 cm anterior to the scalp point and the foot motor cortex, corresponding to the ACC. A naturally cold HF001A coil is used to obtain a greater depth of stimulation, up to about 6 cm subcortical. The coil is an integrated coil for true and false stimulation loops. The intervention protocol is as follows: 30 treatments are given 5 times per week (Monday to Friday) for 6 consecutive weeks. Intervention mode: stimulation frequency 20Hz, stimulation intensity 100% RMT, number of serial pulses 50, sequence interval 20s, a total of 40 trials, 2000 pulses, stimulating the left and right ACC respectively.

CBT+dTMS treatment group

Each patient receives 12 individual sessions of 50 minutes twice a week for 6 weeks.The CBT therapists are nationally registered psychotherapists with systematic professional training and uniform training in CBT for anorexia nervosa to ensure consistency. They are also supervised by a CBT supervisor at the end of each session.

CBT+dTMS treatment groupCBT+pseudo-stimulation group

M-100 Ultimate pulsed magnetic field stimulator is used for dTMS treatment. The coil is positioned 4 cm anterior to the scalp point and the foot motor cortex, corresponding to the ACC (The sham coil has the same parameters as real dTMS and generating the same noise as real coils, but without the magnetic field). A naturally cold HF001A coil is used to obtain a greater depth of stimulation, up to about 6 cm subcortical. The intervention protocol is as follows: 30 treatments are given 5 times per week (Monday to Friday) for 6 consecutive weeks. Intervention mode: stimulation frequency 20Hz, stimulation intensity 100% RMT, number of serial pulses 50, sequence interval 20s, a total of 40 trials, 2000 pulses, stimulating the left and right ACC respectively.

CBT+pseudo-stimulation group

According to national and international guidelines for the treatment of eating disorders, the basic treatment for patients is nutritional therapy, that is, regular and quantitative dietary treatment, with three regular meals followed by a snack meal 2 hours after the regular meal. Both groups received the same nutritional treatment.

CBT+dTMS treatment groupCBT+pseudo-stimulation group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female, aged 18-35 years, right handedness.
  • Above primary education.
  • Meet the diagnostic criteria of AN in DSM-V, and13.0 kg/m2 ≤ body mass index (BMI)\<18.5 kg/m2.
  • No systemic nutritional therapy, psychiatric medication or any form of psychotherapy have been received within 1 month before enrollment.
  • Able to understand the nature of this study and sign an informed consent form.

You may not qualify if:

  • Diagnosed with a DSM-5 disease other than anorexia nervosa, or at high risk of suicide, strong impulsive behavior as well as anti-social behavior.
  • With severe physical or cognitive impairment.
  • Not able to undergo MRI.
  • Considered unsuitable for enrollment in this clinical trial for other reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health

Shanghai, Shanghai Municipality, 200030, China

RECRUITING

MeSH Terms

Conditions

Feeding and Eating DisordersAnorexia Nervosa

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Jue Chen, PHD

    Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Psychosomatic Department in Shanghai Mental Health Center

Study Record Dates

First Submitted

April 17, 2025

First Posted

April 24, 2025

Study Start

April 30, 2025

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

May 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations